-

12:24:42 PM

Covid-19 News Live LIVE

The stock market news feed is automatically updated to show the latest 50 news.

Become a Gold member to see the news in advance and at a faster rate!

Click here to view all today's news.

❮ prevlive news

06/18/21 7:45 AM

Nasdaq : EDSA

Edesa Biotech Reports Favorable Review of COVID-19 Study

Edesa Biotech, Inc. (NASDAQ:EDSA), a clinical-stage biopharmaceutical company focused on inflammatory and immune-related diseases, today reported that an independent Data and Safety Monitoring Board (DSMB) has completed an interim review of the company's

RHEA-AI

neutral

06/17/21 10:38 AM

NYSE : MRK

MSD Announces Supply Agreement with U.S. Government for Molnupiravir, an Investigational Oral Antiviral Candidate for Treatment of Mild to Moderate COVID-19

Merck (NYSE: MRK), known as MSD outside the United States and

RHEA-AI

very positive

06/17/21 10:23 AM

OTC : ZENYF

ZEN Graphene Solutions Announces Exclusive Worldwide Rights to Commercialize Rapid, Saliva-Based COVID-19 Antigen Testing Technology

ZEN Graphene Solutions Ltd. (" ZEN" or the " Company") (TSXV:ZEN)(OTC PINK:ZENYF), a Canadian, next-gen nanomaterials technology company, is pleased to announce that it has signed an exclusive agreement with McMaster University to be the global

RHEA-AI

very positive

06/17/21 7:30 AM

Nasdaq : FLDM

Rover Labs Provides Saliva-based COVID-19 Testing to New York City Public Schools

Rover Labs, a diagnostics technology leader in end-to-end saliva testing, is providing saliva-based COVID-19 testing to approximately 50 New York City public schools during a two-month pilot program that began on June 1 using technology developed by Fluidigm

RHEA-AI

positive

06/17/21 7:17 AM

OTC : APLIF

Appili Therapeutics Inc. Expands PRESECO Clinical Trial of Avigan®/Reeqonus™ for Mild-to-Moderate COVID-19 Patients into Mexico and Brazil

Appili Therapeutics Inc. (TSX: APLI) (OTCQX: APLIF) (the “Company” or “Appili”), a biopharmaceutical company focused on drug development for infectious diseases, has added several clinical research sites in Mexico and Brazil to its Phase 3 clinical trial evaluating Avigan®/Reeqonus™ (favipiravir)

RHEA-AI

neutral

06/17/21 2:00 AM

Nasdaq : TLSA

Tiziana Responds to UK Call for Development of Innovative ‘Take Home’ Treatments for COVID-19 Disease

Tiziana Life Sciences plc (NASDAQ: TLSA, LSE: TILS), a biotechnology company focused on innovative therapeutics for oncology, neurology, inflammation and infectious diseases announces that it has submitted a grant to the United Kingdom COVID

RHEA-AI

very positive

06/16/21 5:19 PM

NYSE : PFE

Data Published in New England Journal of Medicine Shows Pfizer’s Tofacitinib Meets Primary Endpoint in Brazilian Study in Patients Hospitalized with COVID-19 Pneumonia

Pfizer Inc. (NYSE: PFE) and The Academic Research Organization (ARO) from the Hospital Israelita Albert Einstein today announced that the New England Journal of Medicine has published positive findings from the STOP-COVID study (NCT04469114) evaluating the efficacy and safety of oral Janus kinase

RHEA-AI

neutral

06/16/21 5:00 PM

Nasdaq : CVAC

CureVac Provides Update on Phase 2b/3 Trial of First-Generation COVID-19 Vaccine Candidate, CVnCoV

Pivotal study conducted in 10 countries in fast changing environment of at least 29 COVID-19 variant strains; original strain almost completely absent At second interim analysis, statistical success criteria not met. Favorable safety profile confirmed Initial analyses show trend for age and variant

RHEA-AI

neutral

06/16/21 4:01 PM

OTC : CYDY

CytoDyn to Hold Webcast on June 21 to Discuss Unblinded Data from COVID-19 Long-Haulers Trial and Other Developments

CytoDyn Inc. (OTCQB: CYDY), (“CytoDyn” or the “Company"), a late-stage biotechnology company developing leronlimab, a CCR5 antagonist with the potential for multiple therapeutic indications, announced today Nader Pourhassan, Ph.D.,

RHEA-AI

neutral

06/16/21 11:00 AM

NYSE : WMT

Walmart Provides Digital COVID-19 Vaccine Record

Walmart is empowering people with increased access to their health data through a free, secure digital wallet that they own and decide whether to use to share their health information, starting with the COVID-19 vaccine record. The offering provides individuals with an opportunity to securely store

RHEA-AI

neutral

06/16/21 9:06 AM

Nasdaq : XM

EY, SAP and Qualtrics bring leading edge technology to the fight against COVID-19

EY, SAP and Qualtrics (Nasdaq: XM) today announced that governments and businesses across the US and EMEIA are using their collaborative offerings to help in the fight against the COVID-19 pandemic.Through digitizing testing and scheduling, personalizing the

RHEA-AI

positive

06/16/21 8:00 AM

Nasdaq : MRNA

U.S. Government Purchases Additional 200 Million Doses of Moderna’s COVID-19 Vaccine

Moderna, Inc., (Nasdaq: MRNA) a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that the U.S. government has purchased an additional 200 million doses of Moderna’s COVID-19 vaccine, including the option to purchase other COVID-19 vaccine candidates

RHEA-AI

neutral

06/16/21 8:00 AM

NYSE : TRU

Impact of COVID-19 to Household Incomes Reaches Pandemic Low with Recent Graduates Demonstrating the Most Optimism

The percentage of U.S. consumers who said their household income continues to be negatively impacted by COVID-19 dropped to 32% at the beginning of June. This is down

RHEA-AI

neutral

06/16/21 7:00 AM

Nasdaq : EGLX

Enthusiast Gaming Joins Forces with the Ad Council and COVID Collaborative to Promote COVID-19 Vaccine Awareness and Education

Enthusiast Gaming Holdings Inc. (“Enthusiast Gaming” or the “Company”)

RHEA-AI

neutral

06/16/21 1:30 AM

OTC : RLFTF

Relief Therapeutics Reports that Collaboration Partner, NRx Pharmaceuticals, has Announced Additional Results from the Aviptadil U.S. Expanded Access Protocol for Patients with Critical COVID-19

RELIEF THERAPEUTICS Holding AG (SIX:RLF)(OTCQB:RLFTF) (" Relief"), a biopharmaceutical company with its lead compound RLF-100(TM) (aviptadil) in advanced clinical development to treat COVID-19-induced respiratory disorders, reported today that its

RHEA-AI

neutral

06/15/21 10:35 AM

NYSE : SPGI

Q1 2021 S&P 500 Buybacks Double their Post-Covid Low; Companies repurchased 36.5% more shares than in Q4 2020

S&P Dow Jones Indices ("S&P DJI") announced today that preliminary Q1 2021 S&P 500 ® stock buybacks, or share repurchases, were $178.1 billion, a 36.5% increase from Q4 2020's $130.5 billion, and 100.9% above the recent Q2 2020 low of $88.7 billion. The

RHEA-AI

neutral

06/15/21 9:43 AM

Nasdaq : MRNA

Moderna and Magenta Partner to Distribute Moderna’s COVID-19 Vaccine and Updated Variant Booster Candidates in United Arab Emirates

Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, and Magenta Investments, a leading pharmaceutical and healthcare company that is part of an investment and industrial conglomerate in the United Arab Emirates (UAE), today announced a

RHEA-AI

neutral

06/15/21 9:30 AM

Nasdaq : MDCA

MDC Partners (MDCA) and The Harris Poll Present The Covid Consumer Confidence Report, A Canadian vs. American Perspective

MDC Partners agencies Veritas, Union, 6Degrees and Meat & Produce, in collaboration with The Stagwell Group's The Harris Poll, today released the results of its Canadian consumer confidence report following a year of COVID-19.Following Canada's loosening of

RHEA-AI

neutral

06/15/21 9:00 AM

OTC : OTLC

ONCOTELIC CLOSES COVID-19 CLINICAL TRIAL EARLY.

Oncotelic Therapeutics, Inc. (OTCQB:OTLC) ("Oncotelic" or the “Company”), a leading developer of TGF-β therapeutics for oncology, infectious diseases and respiratory health announced that, as of June 11, 2021, Oncotelic has discontinued

RHEA-AI

very negative

06/15/21 8:30 AM

NYSE : FDX

FedEx Delivers 1.35 Million COVID-19 Vaccine Doses to Mexico

FedEx Express, a subsidiary of FedEx Corp. (NYSE: FDX) and the world’s largest express transportation company, today announced that it has safely delivered 1.35 million Johnson & Johnson COVID-19 vaccine doses to Toluca, Mexico, in coordination with Direct Relief and the United States and Mexican

RHEA-AI

neutral

06/15/21 8:17 AM

Nasdaq : BIOC

Biocept Receives More Than 420,000 Samples During First Year of Offering COVID-19 Testing Service

Biocept, Inc. (Nasdaq: BIOC), a leading provider of molecular diagnostic assays, products and services, announces that it has received more than 420,000 samples for SARS-CoV-2 testing since launching this service in June 2020. The samples are processed using Biocept’s RT-PCR-based technology at its

RHEA-AI

very positive

06/15/21 7:30 AM

OTC : BPSR

Organicell Announces Positive Results of Their Expanded Access Trial for the Treatment of Mild to Moderate COVID-19 Using ZofinTM

Organicell Regenerative Medicine, Inc. (OTCMKTS: BPSR), a clinical-stage biopharmaceutical company dedicated to the development of regenerative therapies, today announced the outcome of their expanded access (EA) intermediate size patient population trial (NCT04657406) which:Met endpoints for

RHEA-AI

neutral

06/15/21 7:30 AM

Nasdaq : OCGN

Ocugen Secures Manufacturing Partnership for US Production of COVID-19 Vaccine Candidate, COVAXIN™

Ocugen, Inc. (NASDAQ: OCGN), a biopharmaceutical company focused on discovering, developing, and commercializing gene therapies to cure blindness diseases and developing a vaccine to save

RHEA-AI

neutral

06/14/21 5:20 PM

OTC : AIMD

Ainos Named Exclusive Sales Partner for COVID-19 Antigen Rapid Test Kit in Taiwan

Ainos, Inc. ('we', 'our', or the 'Company'), (OTC PINK:AIMD), entered into an exclusive agreement to serve as the master sales and marketing agent for the Ainos SARS-CoV-2 Antigen Rapid Test Kit ("Covid-19 Test Kit") for Taiwan Carbon Nano Corporation

RHEA-AI

very positive

06/14/21 5:20 PM

OTC : AMAR

Ainos Named Exclusive Sales Partner for COVID-19 Antigen Rapid Test Kit in Taiwan

Ainos, Inc. ('we', 'our', or the 'Company'), (OTC PINK:AIMD), entered into an exclusive agreement to serve as the master sales and marketing agent for the Ainos SARS-CoV-2 Antigen Rapid Test Kit ("Covid-19 Test Kit") for Taiwan Carbon Nano Corporation

RHEA-AI

very positive

06/14/21 4:05 PM

Nasdaq : NVAX

Novavax Announces Positive Results from First Study of Influenza Vaccine and COVID-19 Vaccine Candidate Administered Simultaneously

Novavax, Inc. (Nasdaq: NVAX), a biotechnology company developing next-generation vaccines for serious infectious diseases, today announced data from the first co-administration study of a SARS-CoV-2 vaccine candidate [Novavax, NVX-CoV2373] and an

RHEA-AI

neutral

06/14/21 4:05 PM

OTC : CSLLY

Seqirus Co-Authors First Study to Assess Simultaneous Administration of Seasonal Influenza Vaccine and COVID-19 Vaccine Candidate

Seqirus, a global leader in influenza prevention and a division of CSL Limited (ASX: CSL), today announced that the company co-authored the first study to demonstrate the safety, immunogenicity and efficacy profile of a COVID-19 vaccine when

RHEA-AI

neutral

06/14/21 7:07 AM

Nasdaq : MRNA

Moderna Submits Authorization Application for its COVID-19 Vaccine in Adolescents in Switzerland

Moderna, Inc., (Nasdaq: MRNA) a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that it has submitted an authorization application to Swissmedic for use of its COVID-19 vaccine in adolescents.“We are pleased to announce that we have submitted an

RHEA-AI

neutral

06/14/21 7:01 AM

NYSE : INFO

Average Age of Cars and Light Trucks in the U.S. Rises to 12.1 years, Accelerated by COVID-19, According to IHS Markit

New research from IHS Markit (NYSE: INFO) shows that the average age of light vehicles in operation (VIO) in the U.S. has risen to 12.1 years this year, increasing by nearly 2 months during 2020 and elevated by the COVID-19 pandemic. The increase in average age will further drive vehicle

RHEA-AI

neutral

06/14/21 6:30 AM

Nasdaq : HGEN

Humanigen Initiates Submission for Lenzilumab Marketing Authorization in COVID-19, to the United Kingdom’s Medicines and Healthcare Products Regulatory Agency (MHRA)

Humanigen, Inc. (Nasdaq: HGEN) (“Humanigen”), a clinical-stage biopharmaceutical company focused on preventing and treating an immune hyper-response called ‘cytokine storm’, today announced it has initiated a rolling review submission for Marketing Authorization (MA) by the MHRA for its lead drug

RHEA-AI

positive

06/14/21 6:30 AM

OTC : GWHP

Global WholeHealth Partners Corp. (GWHP-OTC) Acquires Rights to Distribute & Sell Johnson & Johnson COVID-19 Vaccine

via NewMediaWire – Global WholeHealth Partners Corp. (OTC: GWHP), a company that offers one of the largest lines of COVID 19 tests, including SARS-CoV-2 viruses, and that states that its Antibody IgG/IgM tests that they offer are capable of

RHEA-AI

neutral

06/14/21 6:00 AM

Nasdaq : NVAX

Novavax COVID-19 Vaccine Demonstrates 90% Overall Efficacy and 100% Protection Against Moderate and Severe Disease in PREVENT-19 Phase 3 Trial

93% efficacy against predominantly circulating Variants of Concern and Variants of Interest 91% efficacy in high-risk populations 100% efficacy against variants "not considered Variants of Concern/Interest" All COVID-19 hospitalizations/death occurred in the placebo group Company to host investor

RHEA-AI

negative

06/11/21 4:35 PM

NYSE : EBS

COVID-19 Vaccine Drug Substance Manufactured by Emergent BioSolutions Authorized as Part of Johnson & Johnson’s Emergency Use Authorization

Emergent BioSolutions Inc. (NYSE:EBS) today announced that two batches of COVID-19

RHEA-AI

neutral

06/11/21 4:05 PM

Nasdaq : NVAX

Novavax Announces Positive Data from Three Complementary Studies of COVID-19 Beta (B.1.351) Variant Strain Vaccine

Novavax, Inc. (Nasdaq: NVAX), a biotechnology company developing next-generation vaccines for serious infectious diseases, today announced preclinical and clinical data on the company's recombinant protein COVID-19 vaccine candidate, NVX-CoV2373,

RHEA-AI

neutral

06/11/21 3:00 PM

OTC : BOMH

Boomer Holdings Provides Update on Business Outlook and Comments on USA Recovery from Covid-19.

Boomer Holdings, Inc. ("Boomer" or the "Company") (OTCQB: BOMH), is an innovative Consumer Products Company specializing in a large variety of premium quality wellness and everyday use products under the Boomer Naturals brand name. Boomer would like to

RHEA-AI

neutral

06/11/21 8:30 AM

Nasdaq : MRNA

Moderna and Tabuk Pharmaceuticals Partner to Commercialize Moderna’s COVID-19 Vaccine in Saudi Arabia

Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, and Tabuk Pharmaceutical Manufacturing Company (a fully owned subsidiary of Astra Industrial Group), a leading Saudi pharmaceuticals company, today announced an agreement to

RHEA-AI

very positive

06/11/21 7:30 AM

Nasdaq : ADMP

Adamis Provides Update on Clinical Trial Start-Up Progress for Tempol in the Treatment of COVID-19

Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) today announced that clinical trial start-up activities are underway for examining the effects of

RHEA-AI

neutral

06/11/21 6:50 AM

NYSE : BDX

USA Swimming Partners with BD to Provide COVID-19 Screening for the Olympic Trials and Other Competitive Swimming Events

USA Swimming, the national governing body for the sport of swimming in the United States, and BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, have partnered to provide COVID-19 testing at USA Swimming

RHEA-AI

neutral

06/10/21 4:05 PM

NYSE : MTN

Vail Resorts CEO to Donate $29.3 Million from SARs Exercise; Announces Racial Justice as Added Focus Area for Family Foundation

Vail Resorts, Inc. (NYSE: MTN) today announced that Chairman and Chief Executive Officer Rob Katz has exercised stock appreciation rights (SARs) that were set to expire in 2022, and will be making a charitable donation of 100 percent of the proceeds

RHEA-AI

neutral

06/10/21 10:06 AM

Nasdaq : PAYX

Paychex Recognized for Strength of Technology and Service During COVID-19 with HR Tech Award

Paychex, Inc., the HR software and services company that provides the power of simplicity for increasingly complex workplaces, earned a second consecutive HR Tech Award on the strength of the company's client support during the pandemic. Paychex Flex

RHEA-AI

neutral

06/10/21 9:15 AM

Nasdaq : WBA

Walgreens Continues to Boost COVID-19 Vaccination Access Across the Country

As part of the Biden Administration’s National Month of Action, Walgreens will extend pharmacy hours of operation each Friday in June to provide those who may have limited time the additional flexibility needed to get a COVID-19 vaccine. On Friday, June 11, 18 and 25, 4,000 Walgreens pharmacy

RHEA-AI

neutral

06/10/21 9:00 AM

Nasdaq : UPWK

Upwork and Economic Innovation Group to Co-Host Remote Work Event Series Exploring Post-COVID Trends

Upwork Inc. (Nasdaq: UPWK), the world’s work marketplace, and the Economic Innovation Group (EIG) announced today that they will co-host a three-part virtual event series exploring the long-term economic, policy, and geographic impacts of remote work. The series, titled “ Rise of Remote: Exploring

RHEA-AI

neutral

06/10/21 9:00 AM

NYSE : RAD

Rite Aid Extends Vaccinating Hours Every Friday in June to Increase COVID-19 Vaccine Accessibility

Rite Aid (NYSE: RAD) is proud to support the White House and the National Month of Action by extending vaccination hours at select locations in June to make it easier to get vaccinated against COVID-19 and advance equity. This initiative to improve vaccine access and equity, is in accordance with

RHEA-AI

neutral

06/10/21 9:00 AM

NYSE : USB

U.S. Bank Survey: COVID-19 Accelerated Virtual Care, Healthcare Payments Digitization

The COVID-19 pandemic had a significant impact on how consumers received and paid for their visits to hospitals, clinics, urgent care centers and doctor’s offices in 2020, a new survey from U.S. Bank revealed.The key findings:Virtual care and contactless payment methods ruled: Almost two-thirds

RHEA-AI

neutral

06/10/21 8:30 AM

Nasdaq : NOVN

Novan Announces Positive Preclinical Data in SB019 COVID-19 Anti-Viral Therapy Program

– Data indicate that berdazimer sodium prevents progression of SARS-CoV-2 infection in two independent in vivo transmission studies – – Statistically significant, dose-dependent reduction in the amount of virus in the lung with doses as low as 2 mg/mL – – Preliminary toxicology and pharmacology

RHEA-AI

neutral

06/10/21 8:00 AM

Nasdaq : MRNA

Moderna Files for Emergency Use Authorization for its COVID-19 Vaccine in Adolescents in the United States

Moderna, Inc., (Nasdaq: MRNA) a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that it has requested an emergency use authorization (EUA) for its COVID-19 vaccine in adolescents with the U.S. Food and Drug Administration (FDA).“We are pleased to

RHEA-AI

neutral

06/10/21 7:30 AM

Nasdaq : OCGN

Ocugen to pursue a BLA path in the US for its COVID-19 vaccine candidate

Ocugen, Inc. (NASDAQ: OCGN) (Company), a

RHEA-AI

neutral

06/10/21 2:00 AM

NYSE, Nasdaq : PFE, BNTX

Pfizer and BioNTech to Provide 500 Million Doses of COVID-19 Vaccine to U.S. Government for Donation to Poorest Nations

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced plans to provide the U.S. government at a not-for-profit price 500 million doses of the companies’ COVID-19 vaccine, 200 million doses in 2021 and 300 million doses in the first half of 2022, to further support the multilateral

RHEA-AI

neutral

06/10/21 2:00 AM

Nasdaq : BNTX

Pfizer and BioNTech to Provide 500 Million Doses of COVID-19 Vaccine to U.S. Government for Donation to Poorest Nations

U.S. government to purchase at not-for-profit price 200 million doses in 2021 and 300 million in the first half of 2022 Doses to be donated to approximately 100 low- and lower middle-income countries including those in the African Union via the COVAX Facility Effort is part of the companies’ recent

RHEA-AI

neutral

06/09/21 9:00 AM

OTC : SBFM

Sunshine Biopharma Mice Study for COVID-19 Treatment Progressing as Planned

Sunshine Biopharma Inc. (OTC PINK: “SBFM”), a pharmaceutical company focused on the research, development and commercialization of oncology and antiviral drugs, today confirmed that its COVID-19 mice study currently underway at the University of Georgia

RHEA-AI

neutral

❮ prevlive news